QPS Miami

The QPS location in Miami, Florida is a multi-specialty research center with 150+ employees, including board-certified physicians, in a 32,000 square foot space.

Core Competencies

Phase I → IV clinical trials.
Phase I study types include: SAD/MAD, BE/BA, PK/PD, food effects, QTC, proof of concept, drug interactions and biologics.
Study patient populations include: elderly, pediatrics, and post-menopausal women.
Study Indications include: NASH, fatty liver, diabetes, OA/RA, ADHD, depression, sleep, vaccine, Parkinson’s disease, Alzheimer’s disease, migraines, gout, male hypogonadism, obesity, cholesterol, hypertension, renal/hepatic impairment, women’s health, and more.
Vaccine research study experience includes: Zika, Ebola, Human Papillomavirus (HPV), Human Immunodeficiency Virus (HIV), Respiratory Syncytial Virus (RSV), Pneumococcus, Influenza, and more.
Full-service clinical laboratory.
Peripheral blood mononuclear cell (PBMC) laboratory.
USP 797-compliant pharmacy with compounding capability.

Facility

90-bed Phase I unit.
Late Phase clinical trial facility.
Access to Wireless Telemetry, Ultrasound, Dual Energy X-Ray Absorptiometry (DEXA), Polysomnography (PSG), Magnetic Resonance Angiography (MRA), Computed Tomography (CT), X-Ray, and Holter monitoring.
Refrigerated centrifuges.
Electronic lab transfers.
RSVP system – a fingerprinting system to prevent patients from entering multiple trials at the same time.
Sleep lab.
In-house specialized patient recruitment and advertising agency.
Call-center staffed with experienced research counselors.

People

5 principal investigators (PIs), board-certified in various fields, including rheumatology, internal medicine, psychiatry, neurology, sleep, dermatology, and gastroenterology, with additional access to a wide variety of specialty physicians.
5 nurse practitioners.
2 pharmacists.
15 nurses.
30 support staff including: study coordinators (with, on average, 6 years of research experience), QA/QC personnel, nurses, and regulatory personnel.

Achievements

13 routine FDA audits over the past 11 years and no 483s issued.
A robust database of 30,000 subjects/patients.

Accreditation

Association for the Accreditation of Human Research Protection Program (AAHRPP) accredited.
Lab is Clinical Laboratory Improvement Amendments (CLIA) and Commission on Office Laboratory Accreditation (COLA) accredited.
All staff are trained in good clinical practices (GCP).
Coordinators are trained on basic life support (BLS).